Chempath - Hyper and Hypoglycaemia Flashcards
General causes of hyperglycaemia
Increased insulin resistance
Absolut insulin deficiency
Diagnosis DM
Either typical symptoms plus one of Fasting glucose >7, Oral glucose tolerance test >11.1 or random glucose >11.1
OR made without symptoms via 2 of the above tests.
OR HbA1c >6.5% (48mmol/mol)
Values for impaired glucose tolerance and impaired fasting glucose
IGT- Random or oral glucose tolerance test >7.8 but <11.1
IFG - fasting glucose >6.1 but <7.0
Hyperosmolar hyperglycaemic state (HHS) Criteria
T2DM
pH > 7.3
Osmolarity > 320mOsm
Blood Glucose > 30mM
Clinically: present similarly to DKA, acutely unwell with confusion and clinical dehydration. May lose unto 20% of body weight in fluid losses.
HHS Rx
Fluid replacement – Aggressive, can usually use normal saline +/- potassium. Aim +3-6L by 12h depending on weight and extent of dehydration. Aiming to reduce Glucose no more than 5mM/h and Na+ by 10mM/24h.
Monitoring - Serial U+Es and glucose readings
Potassium - Supplementation only needed if K+ between 3.5-5.5
Insulin - Can be used if glucose no longer falling with fluids alone. Use 0.05u/Kg/hr fixed dose.
Monitor pressure areas – high risk of ulceration
Monitor neuro obs
DKA Criteria
pH < 7.3
Plasma Glucose >11mM
Blood Ketones>3mM (2+ in urine)
Clinically:
Medical emergency, presenting with collapse/confusion, a dehydrated/shocked patient, may be associated with kussmaul breathing, abdominal pain, nausea, vomiting. Precipitants include: Infection, surgery, missed insulin doses, trauma (hypercortisolism increases insulin resistance). Patients lose up to 10% of bodyweight in water.
DKA Rx
Identify and treat cause/trigger
Bloods (inc VBG unless concerns over respiratory function where ABG would be more appropriate), ECG, spot ketones + glucose.
Fluids - These must be started first. Replacement of deficit + maintenance over 24h. Front load replacement and taper off gradually. N. Saline is fluid of choice. If potassium low add in 40mM KCl (n.b. you cannot administer
>10mM/h K+ outside of ITU). Supplement if <5.5 even if bloods seem fine as there will be a big shift when you start insulin (exchange with H+).
Insulin - Started after fluids, ensure K+ not <3.5, 0.1u/kg/h fixed dose regimen. DO NOT STOP background basal insulin – the state of deficiency the patient is in is in the context of this being present. Once BM drops to <15, give 10% dextrose to prevent rebound hypoglycaemia.
Early senior review +/- ITU involvement
Monitoring- Aiming to reduce Ketones by 0.5/h and glucose by around 3/h. Hourly VBG for K+ and HCO3- - aim to keep serum K+ >4. Catheterisation is useful, aiming O/P >0.5ml/kg/hr.
Resolution is when ketones <0.6 and pH >7.3
TD1M HLA associations
HLA DR3 and DR4
What happens to acid-base balance in a metformin overdose?
Lactic acidosis (metabolic acidosis with high anion gap)
Causes of hyperinsulinaemic hypoglycaemia with reduced C-peptide
Exogenous insulin: Poor patient understandin g of therapy Inappropriate insulin delivery method for patient [e.g. unable to appropriately titrate dose/see units on insulin pen] Intentional inappropriate use (?Psychiatric concerns)
Causes of hyperinsulinaemic hypoglycaemia with appropriate C-peptide
Endogenous cause:
Insulinoma (requires -ve sulphonylurea screen- C-pep increased by sulphonylureas)
Quinine
Pentamidine (for too, PCP, leishmania)
Islet cell hyperplasia - infant of diabetic mother
Beckwith Weide-Mann syndrome
Nesidioblastosis
Hypoinsulinaemic hypoglycaemia, adults
Fasting Strenuous exercise Critical illness Endo def (hypo-it, adrenal failure) Liver failure Anorexia nervosa
Hypoinsulinaemic hypoglycaemia, neonates - ketones present
Premature
IUGR/SGA - inadequate glycogen/fat stores
Co-morbidity
Hypoinsulinaemic hypoglycaemia, neonates - ketones absent
Inherited metabolic disorder
Non-islet cell tumours
↓ Glucose, ↓ Insulin, ↓ C-peptide, ↓FFA and ↓ Ketones
Tumours that cause a paraneoplastic syndrome, secreting ‘big IGF-2’, which binds to IGF-1 and Insulin receptors.
Mesenchymal tumours (mesothelioma/fibroblastoma), epithelial tumours (carcinoma).